|Alliance Global Partners||James Molloy|
|Canaccord Genuity||John Newman|
|Cantor Fitzgerald||Kristen Kluska|
|Encode Ideas||Hogan Mullaley|
|Jones Trading||Prakhar Agrawal|
|Spartan Capital||Javier Fonseca|
Ocuphire Pharma, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ocuphire Pharma, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Ocuphire Pharma, Inc. or its management. Ocuphire Pharma, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.